Drug Repositioning: Current Advances and Future Perspectives
Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...
Saved in:
Main Author: | Yuhei Nishimura (auth) |
---|---|
Other Authors: | Hideaki Hara (auth) |
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Frontiers Media SA
2019
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Strategies for Prospective Drug Repositionings
Published: (2022) -
In Silico Strategies for Prospective Drug Repositionings
Published: (2023) -
Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design
Published: (2019) -
Pharmacokinetics and Drug Metabolism in Canada: The Current Landscape
by: Neal M. Davies (Ed.)
Published: (2018) -
Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
Published: (2021)